HDL lipids and insulin resistance

Current Diabetes Reports

Volumn 10, Issue 1, 2010, Pages 78-86

  Hoofnagle, Andrew N ^a   Vaisar, Tomas ^a   Mitra, Poulami ^a   Chait, Alan ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose tissue; Ceramide; Dysfunctional high density lipoprotein; Endothelial; Inflammation; Insulin resistance; Lipids; Lipoproteins; Macrophage; Obesity; Phospholipid; Sphingomyelin; Sphingosine 1 phosphate

Indexed keywords

ABC TRANSPORTER A1; CERAMIDE; CHYLOMICRON; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; FINGOLIMOD; FISH OIL; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL OBESITY; ALCOHOLISM; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CELL FATE; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; HEART INFARCTION; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; METABOLIC SYNDROME X; NIEMANN PICK DISEASE; NONHUMAN; OBESITY; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CERAMIDES; CHOLESTEROL, HDL; HUMANS; INSULIN RESISTANCE; LYSOPHOSPHOLIPIDS; SIGNAL TRANSDUCTION; SPHINGOMYELINS; SPHINGOSINE;

EID: 77249083069     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-009-0085-7     Document Type: Review

References (78)

1. GJ Miller 1980 HDL and atherosclerosis Annu Rev Med 31 97 108 10.1146/annurev.me.31.020180.000525 1:STN:280:DyaL3c3ktVOnsg%3D%3D 6994629
2. B Garner AR Waldeck PK Witting, et al. 1998 Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII J Biol Chem 273 6088 6095 10.1074/jbc.273.11.6088 1:CAS:528:DyaK1cXitFalsro%3D 9497326 (Pubitemid 28144688)
3. PJ Barter S Nicholls KA Rye, et al. 2004 Antiinflammatory properties of HDL Circ Res 95 764 772 10.1161/01.RES.0000146094.59640.13 1:CAS:528: DC%2BD2cXot1aitrY%3D 15486323 (Pubitemid 39390578)
4. ST Reddy A Devarajan N Bourquard, et al. 2008 Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis? Curr Opin Lipidol 19 405 408 10.1097/MOL.0b013e328304b64e 1:CAS:528: DC%2BD1cXotFOmt74%3D 18607188
5. DM Stafforini 2009 Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2) Cardiovasc Drugs Ther 23 73 83 10.1007/s10557-008-6133-8 1:CAS:528:DC%2BD1MXotVyrtw%3D%3D 18949548
6. T Vaisar S Pennathur PS Green, et al. 2007 Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL J Clin Invest 117 746 756 10.1172/JCI26206 1:CAS:528: DC%2BD2sXis12htLs%3D 17332893 (Pubitemid 46348533)
7. AN Hoofnagle JW Heinecke 2009 Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins J Lipid Res 50 1967 1975 10.1194/jlr.R900015-JLR200 1:CAS:528:DC%2BD1MXhtF2qsLjE 19738003
8. MA Connelly 2009 SR-BI-mediated HDL cholesteryl ester delivery in the adrenal gland Mol Cell Endocrinol 300 83 88 10.1016/j.mce.2008.09.011 1:CAS:528:DC%2BD1MXitVOlsb8%3D 18840501
9. P Wiesner K Leidl A Boettcher, et al. 2009 Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry J Lipid Res 50 574 585 10.1194/jlr.D800028-JLR200 1:CAS:528:DC%2BD1MXitlCqtbg%3D 18832345
10. AA Kandutsch HW Chen HJ Heiniger 1978 Biological activity of some oxygenated sterols Science 201 498 501 10.1126/science.663671 1:STN:280:DyaE1c3gsValsw%3D%3D 663671
11. BA Janowski PJ Willy TR Devi, et al. 1996 An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha Nature 383 728 731 10.1038/383728a0 1:CAS:528:DyaK28XmsVGns78%3D 8878485 (Pubitemid 26360651)
12. I Burkard A von Eckardstein G Waeber, et al. 2007 Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers Atherosclerosis 194 71 78 10.1016/j.atherosclerosis.2006.09. 026 17107679 (Pubitemid 47464309)
13. AJ Brown W Jessup 1999 Oxysterols and atherosclerosis Atherosclerosis 142 1 28 10.1016/S0021-9150(98)00196-8 1:CAS:528:DyaK1cXnt1arsLg%3D 9920502 (Pubitemid 28553934)
14. N Yoshioka J Adachi Y Ueno K Yoshida 2005 Oxysterols increase in diabetic rats Free Radic Res 39 299 304 10.1080/10715760400023002 1:CAS:528: DC%2BD2MXitlCkt70%3D 15788234 (Pubitemid 40439392)
15. MJ Tikkanen V Vihma M Jauhiainen, et al. 2002 Lipoprotein-associated estrogens Cardiovasc Res 56 184 188 10.1016/S0008-6363(02)00535-7 1:CAS:528:DC%2BD38XotVCjs7o%3D 12393088 (Pubitemid 35223488)
16. M Gong M Wilson T Kelly, et al. 2003 HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner J Clin Invest 111 1579 1587 1:CAS:528:DC%2BD3sXktVGisbw%3D 12750408
17. RM Badeau J Metso K Wahala, et al. 2009 Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17beta-estradiol fatty acyl esters J Steroid Biochem Mol Biol 116 44 49 10.1016/j.jsbmb.2009.04.008 1:CAS:528:DC%2BD1MXnvValtLg%3D 19406243
18. W Zhang B Asztalos PS Roheim L Wong 1998 Characterization of phospholipids in pre-alpha HDL: selective phospholipid efflux with apolipoprotein A-I J Lipid Res 39 1601 1607 1:CAS:528:DyaK1cXlsVansbY%3D 9717720
19. WS Davidson KL Gillotte S Lund-Katz, et al. 1995 The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol J Biol Chem 270 5882 5890 10.1074/jbc.270.11.5882 1:CAS:528:DyaK2MXksVCntrc%3D 7890719
20. JJ Myher A Kuksis WC Breckenridge JA Little 1981 Differential distribution of sphingomyelins among plasma lipoprotein classes Can J Biochem 59 626 636 1:CAS:528:DyaL3MXls1Chtb8%3D 7296345
21. RS Kiss DC McManus V Franklin, et al. 2003 The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways J Biol Chem 278 10119 10127 10.1074/jbc.M300137200 1:CAS:528: DC%2BD3sXitVCkt7k%3D 12547832 (Pubitemid 36800269)
22. XC Jiang C Bruce J Mar, et al. 1999 Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels J Clin Invest 103 907 914 10.1172/JCI5578 1:CAS:528:DyaK1MXhvFarsrk%3D 10079112
23. W Pruzanski E Stefanski FC de Beer, et al. 2000 Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins J Lipid Res 41 1035 1047 1:CAS:528:DC%2BD3cXltF2qtr4%3D 10884283
24. T Matsumoto T Kobayashi K Kamata 2007 Role of lysophosphatidylcholine (LPC) in atherosclerosis Curr Med Chem 14 3209 3220 10.2174/092986707782793899 1:CAS:528:DC%2BD1cXhtlSrsbs%3D 18220755
25. A Nilsson RD Duan 2006 Absorption and lipoprotein transport of sphingomyelin J Lipid Res 47 154 171 10.1194/jlr.M500357-JLR200 1:CAS:528:DC%2BD28XpvVekuw%3D%3D 16251722 (Pubitemid 43107459)
26. KE Winkler JB Marsh 1989 Characterization of nascent high density lipoprotein subfractions from perfusates of rat liver J Lipid Res 30 979 987 1:CAS:528:DyaL1MXltlWgt74%3D 2794796
27. 3.
28. AJ Guarino SP Lee SP Wrenn 2006 Interactions between sphingomyelin and cholesterol in low density lipoproteins and model membranes J Colloid Interface Sci 293 203 212 10.1016/j.jcis.2005.06.043 1:CAS:528:DC%2BD2MXht1ahtrvE 16019021 (Pubitemid 41635350)
29. SY Morita M Kawabe A Sakurai, et al. 2004 Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages J Biol Chem 279 24355 24361 10.1074/jbc.M402035200 1:CAS:528:DC%2BD2cXksV2itrY%3D 15044445 (Pubitemid 38725298)
30. SY Morita M Nakano A Sakurai, et al. 2005 Formation of ceramide-enriched domains in lipid particles enhances the binding of apolipoprotein E FEBS Lett 579 1759 1764 10.1016/j.febslet.2005.02.018 1:CAS:528:DC%2BD2MXitFChsL0%3D 15757672 (Pubitemid 40341554)
31. •• Devlin CM, Leventhal AR, Kuriakose G, et al.: Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler Thromb Vasc Biol 2008, 28:1723-1730. In two mouse models of atherosclerosis, the authors demonstrated that genetic deficiency of acid sMase protects from early lipoprotein retention and atherogenesis. The paper provides compelling experimental evidence from an in vivo model to support the proposed role of the enzymatic conversion of SM to ceramide in lipoprotein aggregation and retention, and subsequent atherosclerotic lesion development.
32. PV Subbaiah P Horvath SB Achar 2006 Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate Biochemistry 45 5029 5038 10.1021/bi0600704 1:CAS:528:DC%2BD28Xis1Kiur4%3D 16605271
33. CY Lee A Lesimple M Denis, et al. 2006 Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B J Lipid Res 47 622 632 10.1194/jlr.M500487-JLR200 1:CAS:528:DC%2BD28XisVagu7g%3D 16319418 (Pubitemid 43345603)
34. P Marmillot J Munoz S Patel, et al. 2007 Long-term ethanol consumption impairs reverse cholesterol transport function of high-density lipoproteins by depleting high-density lipoprotein sphingomyelin both in rats and in humans Metabolism 56 947 953 10.1016/j.metabol.2007.03.003 1:CAS:528: DC%2BD2sXmsF2jt78%3D 17570257 (Pubitemid 46890978)
35. PG Yancey M de la Llera-Moya S Swarnakar, et al. 2000 High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI J Biol Chem 275 36596 36604 10.1074/jbc.M006924200 1:CAS:528:DC%2BD3cXoslWmtbk%3D 10964930 (Pubitemid 32002059)
36. S Lightle R Tosheva A Lee, et al. 2003 Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase Arch Biochem Biophys 419 120 128 10.1016/j.abb.2003.08.031 1:CAS:528:DC%2BD3sXosVyhu78%3D 14592455 (Pubitemid 37329978)
37. A Kuksis JJ Myher K Geher, et al. 1981 Lipid class and molecular species interrelationships among plasma lipoproteins of normolipemic subjects J Chromatogr 224 1 23 10.1016/S0378-4347(00)80133-4 1:CAS:528:DyaL3MXktl2qtL0%3D 7263806
38. K Sattler B Levkau 2009 Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection Cardiovasc Res 82 201 211 10.1093/cvr/cvp070 1:CAS:528:DC%2BD1MXksVaktLg%3D 19233866
39. R Pappu SR Schwab I Cornelissen, et al. 2007 Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate Science 316 295 298 10.1126/science.1139221 1:CAS:528:DC%2BD2sXktVeku70%3D 17363629 (Pubitemid 46633109)
40. G Dawson AW Kruski AM Scanu 1976 Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias J Lipid Res 17 125 131 1:CAS:528:DyaE28XktFynsb8%3D 178813
41. HJ Senn M Orth E Fitzke, et al. 1989 Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins Eur J Biochem 181 657 662 10.1111/j.1432-1033.1989.tb14773.x 1:CAS:528:DyaL1MXksFCktb0%3D 2731542 (Pubitemid 19146930)
42. WC Breckenridge FB Palmer 1982 Fatty acid composition of human plasma lipoprotein phosphatidylinositols Biochim Biophys Acta 712 707 711 1:CAS:528:DyaL38Xlsl2nt7o%3D 7126634
43. WS Davidson DL Sparks S Lund-Katz MC Phillips 1994 The molecular basis for the difference in charge between pre-beta- and alpha-migrating high density lipoproteins J Biol Chem 269 8959 8965 1:CAS:528:DyaK2cXktVenurg%3D 8132633
44. JG Boucher T Nguyen DL Sparks 2007 Lipoprotein electrostatic properties regulate hepatic lipase association and activity Biochem Cell Biol 85 696 708 10.1139/O07-137 1:CAS:528:DC%2BD1cXovVelsg%3D%3D 18059528 (Pubitemid 351198417)
45. EA Bonomo JB Swaney 1990 Effect of phosphatidylethanolamine on the properties of phospholipid-apolipoprotein complexes Biochemistry 29 5094 5103 10.1021/bi00473a014 1:CAS:528:DyaK3cXitlWntb4%3D 2116166 (Pubitemid 20189147)
46. IS Thind RS Sandhu 1981 Signification of high density and total cholesterol and triglycerides in acute myocardial infarction-a case-control study Clin Biochem 14 57 60 10.1016/S0009-9120(81)90670-6 1:STN:280: DyaL38%2FkvFShsQ%3D%3D 7296813
47. VH Sunesen C Weber G Holmer 2001 Lipophilic antioxidants and polyunsaturated fatty acids in lipoprotein classes: distribution and interaction Eur J Clin Nutr 55 115 123 10.1038/sj.ejcn.1601127 1:CAS:528: DC%2BD3MXhsFGrur0%3D 11305624
48. WA Behrens JN Thompson R Madere 1982 Distribution of alpha-tocopherol in human plasma lipoproteins Am J Clin Nutr 35 691 696 1:CAS:528:DyaL38XitFGjtLc%3D 7072621
49. MG Traber SR Diamond JC Lane, et al. 1994 beta-Carotene transport in human lipoproteins. Comparisons with alpha-tocopherol Lipids 29 665 669 10.1007/BF02538909 1:CAS:528:DyaK2cXmsFaitLY%3D 7861932 (Pubitemid 24321172)
50. • Sano O, Kobayashi A, Nagao K, et al.: Sphingomyelin-dependence of cholesterol efflux mediated by ABCG1. J Lipid Res 2007, 48:2377-2384. The authors use a multipronged cell biological approach to show that cellular SM concentrations help control the rate of cholesterol efflux by the cell-membrane transporter ABCG1.
51. D Lucic ZH Huang D Gu, et al. 2007 Cellular sphingolipids regulate macrophage apolipoprotein E secretion Biochemistry 46 11196 11204 10.1021/bi701106v 1:CAS:528:DC%2BD2sXpslSiu7c%3D 17760463 (Pubitemid 47502785)
52. SR Witting JN Maiorano WS Davidson 2003 Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1 J Biol Chem 278 40121 40127 10.1074/jbc.M305193200 1:CAS:528:DC%2BD3sXnvFamsb0%3D 12890677 (Pubitemid 37248579)
53. XA Li WB Titlow BA Jackson, et al. 2002 High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner J Biol Chem 277 11058 11063 10.1074/jbc.M110985200 1:CAS:528:DC%2BD38Xis1KhurY%3D 11792700 (Pubitemid 34952864)
54. JR Nofer M van der Giet M Tolle, et al. 2004 HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 J Clin Invest 113 569 581 1:CAS:528:DC%2BD2cXhsFKhsbg%3D 14966566
55. Camino-Lopez S, Badimon L, Gonzalez A, et al.: Aggregated LDL induces tissue factor by inhibiting sphingomyelinase activity in human vascular smooth muscle cells. J Thromb Haemost 2009 Oct 8 (Epub ahead of print).
56. B Boyanovsky A Karakashian K King, et al. 2003 Uptake and metabolism of low density lipoproteins with elevated ceramide content by human microvascular endothelial cells: implications for the regulation of apoptosis J Biol Chem 278 26992 26999 10.1074/jbc.M301536200 1:CAS:528:DC%2BD3sXltlKqtbw%3D 12721293 (Pubitemid 36876853)
57. RS Hundal A Gomez-Munoz JY Kong, et al. 2003 Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL levels J Biol Chem 278 24399 24408 10.1074/jbc.M209179200 1:CAS:528:DC%2BD3sXltVSmtL0%3D 12750385 (Pubitemid 37548591)
58. A Loidl R Claus E Ingolic, et al. 2004 Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells Biochim Biophys Acta 1690 150 158 1:CAS:528:DC%2BD2cXot12it70%3D 15469904
59. G Daum A Grabski MA Reidy 2009 Sphingosine 1-phosphate: a regulator of arterial lesions Arterioscler Thromb Vasc Biol 29 1439 1443 10.1161/ATVBAHA.108. 175240 1:CAS:528:DC%2BD1MXhtFWhtbbL 19592471
60. M Navab ST Reddy BJ Van Lenten, et al. 2009 The role of dysfunctional HDL in atherosclerosis J Lipid Res 50 Suppl S145 S149 10.1194/jlr.R800036-JLR200 18955731
61. AE Alewijnse SL Peters 2008 Sphingolipid signalling in the cardiovascular system: good, bad or both? Eur J Pharmacol 585 292 302 10.1016/j.ejphar.2008. 02.089 1:CAS:528:DC%2BD1cXls1Snt74%3D 18420192
62. JR Nofer M Bot M Brodde, et al. 2007 FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice Circulation 115 501 508 10.1161/ CIRCULATIONAHA.106.641407 1:CAS:528:DC%2BD2sXnvF2mtw%3D%3D 17242282 (Pubitemid 46188244)
63. P Keul M Tolle S Lucke, et al. 2007 The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 27 607 613 10.1161/01.ATV.0000254679.42583.88 1:CAS:528:DC%2BD2sXhsVSitro%3D 17158351 (Pubitemid 46263407)
64. AM Whetzel DT Bolick S Srinivasan, et al. 2006 Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor Circ Res 99 731 739 10.1161/01.RES.0000244088. 33375.52 1:CAS:528:DC%2BD28XpvFert70%3D 16960101 (Pubitemid 44498306)
65. T Kimura H Tomura C Mogi, et al. 2006 Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells Cell Signal 18 841 850 10.1016/j.cellsig.2005.07. 011 1:CAS:528:DC%2BD28Xhtlakurw%3D 16111867 (Pubitemid 43208937)
66. W Khovidhunkit MS Kim RA Memon, et al. 2004 Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host J Lipid Res 45 1169 1196 10.1194/jlr.R300019-JLR200 1:CAS:528:DC%2BD2cXltFyqs78%3D 15102878 (Pubitemid 38802622)
67. S Fenkci S Rota N Sabir, et al. 2006 Relationship of serum interleukin-6 and tumor necrosis factor alpha levels with abdominal fat distribution evaluated by ultrasonography in overweight or obese postmenopausal women J Investig Med 54 455 460 10.2310/6650.2006.06010 1:CAS:528:DC%2BD2sXitV2ju74%3D 17169269 (Pubitemid 46146127)
68. •• Kolak M, Westerbacka J, Velagapudi VR, et al.: Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007, 56:1960-1968. The authors used state-of-the-art lipidomic techniques to evaluate the adipose tissue lipidome from individuals with hepatic steatosis and insulin resistance. Their finding of increased ceramide levels suggests an important role for this lipid in the pathogenesis of insulin resistance.
69. GM Deevska KA Rozenova NV Giltiay, et al. 2009 Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice J Biol Chem 284 8359 8368 10.1074/jbc.M807800200 1:CAS:528:DC%2BD1MXjsVSisLo%3D 19074137
70. SA Summers 2006 Ceramides in insulin resistance and lipotoxicity Prog Lipid Res 45 42 72 10.1016/j.plipres.2005.11.002 1:CAS:528:DC%2BD28XhtV2ksbg%3D 16445986 (Pubitemid 43170804)
71. G Yang L Badeanlou J Bielawski, et al. 2009 Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome Am J Physiol Endocrinol Metab 297 E211 E224 10.1152/ajpendo.91014.2008 1:CAS:528:DC%2BD1MXovVKjtLo%3D 19435851
72. M Monetti MC Levin MJ Watt, et al. 2007 Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver Cell Metab 6 69 78 10.1016/j.cmet.2007.05.005 1:CAS:528:DC%2BD2sXotlCitLg%3D 17618857 (Pubitemid 46995777)
73. Kotronen A, Seppanen-Laakso T, Westerbacka J, et al.: Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity (Silver Spring) 2009 Oct 1 (Epub ahead of print).
74. M Lankinen U Schwab A Erkkila, et al. 2009 Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach PLoS One 4 e5258 10.1371/journal.pone.0005258 19390588
75. • Kendall MR, Hupfeld CJ: FTY720, a sphingosine-1-phosphate receptor modulator, reverses high-fat diet-induced weight gain, insulin resistance and adipose tissue inflammation in C57BL/6 mice. Diabetes Obes Metab 2008, 10:802-805. This brief article raises some interesting new possibilities regarding interaction of S1P with its receptors in improving insulin resistance; this needs to be followed up with more extensive studies.
76. Z Tu C Argmann KK Wong, et al. 2009 Integrating siRNA and protein-protein interaction data to identify an expanded insulin signaling network Genome Res 19 1057 1067 10.1101/gr.087890.108 1:CAS:528:DC%2BD1MXntFGrsLY%3D 19261841
77. E Rapizzi ML Taddei T Fiaschi, et al. 2009 Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor Cell Mol Life Sci 66 3207 3218 10.1007/s00018-009-0106-3 1:CAS:528:DC%2BD1MXhtFCitrvI 19662499
78. S Rutti JA Ehses RA Sibler, et al. 2009 Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells Endocrinology 150 4521 4530 10.1210/en.2009-0252 1:CAS:528:DC%2BD1MXht1Oktr3I 19628574